These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34178988)

  • 1. LncRNA HCP5 Induces Gastric Cancer Cell Proliferation, Invasion, and EMT Processes Through the miR-186-5p/WNT5A Axis Under Hypoxia.
    Gao M; Liu L; Yang Y; Li M; Ma Q; Chang Z
    Front Cell Dev Biol; 2021; 9():663654. PubMed ID: 34178988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of long non-coding RNA HCP5 inhibits proliferation, invasion, migration, and promotes apoptosis via regulation of miR-299-3p/SMAD5 axis in gastric cancer cells.
    Yin D; Lu X
    Bioengineered; 2021 Dec; 12(1):225-239. PubMed ID: 33371778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MEF2A-mediated lncRNA HCP5 Inhibits Gastric Cancer Progression via MiR-106b-5p/p21 Axis.
    Chen W; Zhang K; Yang Y; Guo Z; Wang X; Teng B; Zhao Q; Huang C; Qiu Z
    Int J Biol Sci; 2021; 17(2):623-634. PubMed ID: 33613117
    [No Abstract]   [Full Text] [Related]  

  • 4. The Effect of Long Non-Coding RNA (lncRNA) HCP5 on Regulating Epithelial-Mesenchymal Transition (EMT)-Related Markers in Gastric Carcinoma Is Partially Reversed by miR-27b-3p.
    Chen S; Ren C; Zheng H; Sun X; Dai J
    Med Sci Monit; 2020 May; 26():e921383. PubMed ID: 32357145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long Non-Coding RNA HCP5 Facilitates Cell Invasion And Epithelial-Mesenchymal Transition In Oral Squamous Cell Carcinoma By miR-140-5p/SOX4 Axis.
    Zhao J; Bai X; Feng C; Shang X; Xi Y
    Cancer Manag Res; 2019; 11():10455-10462. PubMed ID: 31849534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA HCP5 contributes to epithelial-mesenchymal transition in colorectal cancer through ZEB1 activation and interacting with miR-139-5p.
    Yang C; Sun J; Liu W; Yang Y; Chu Z; Yang T; Gui Y; Wang D
    Am J Transl Res; 2019; 11(2):953-963. PubMed ID: 30899394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of lncRNAHCP5/microRNA-525-5p/PRC1 crosstalk in the malignant behaviors of ovarian cancer cells.
    Wang L; He M; Fu L; Jin Y
    Exp Cell Res; 2020 Sep; 394(1):112129. PubMed ID: 32511950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA HCP5 Regulates Pancreatic Cancer Progression by miR-140-5p/CDK8 Axis.
    Yuan B; Guan Q; Yan T; Zhang X; Xu W; Li J
    Cancer Biother Radiopharm; 2020 Nov; 35(9):711-719. PubMed ID: 32407143
    [No Abstract]   [Full Text] [Related]  

  • 9. Long non-coding RNA HCP5 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-140-5p/IGF1R pathway.
    Zhang YJ; Lu C
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):2965-2975. PubMed ID: 32271414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of Circ_0081143 Mitigates Hypoxia-Induced Migration, Invasion, and EMT in Gastric Cancer Cells Through the miR-497-5p/EGFR Axis.
    Tang J; Zhu H; Lin J; Wang H
    Cancer Biother Radiopharm; 2021 May; 36(4):333-346. PubMed ID: 32678674
    [No Abstract]   [Full Text] [Related]  

  • 11. miR-26a-5p Inhibit Gastric Cancer Cell Proliferation and Invasion Through Mediated Wnt5a.
    Li Y; Wang P; Wu LL; Yan J; Pang XY; Liu SJ
    Onco Targets Ther; 2020; 13():2537-2550. PubMed ID: 32273724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA HCP5 knockdown inhibits high glucose-induced excessive proliferation, fibrosis and inflammation of human glomerular mesangial cells by regulating the miR-93-5p/HMGA2 axis.
    Wang X; Liu Y; Rong J; Wang K
    BMC Endocr Disord; 2021 Jun; 21(1):134. PubMed ID: 34187448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HCP5 Promotes Proliferation and Contributes to Cisplatin Resistance in Gastric Cancer Through miR-519d/HMGA1 Axis.
    Zhang Z; Wang H
    Cancer Manag Res; 2021; 13():787-794. PubMed ID: 33536786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA HULC promotes the progression of gastric cancer by regulating miR-9-5p/MYH9 axis.
    Liu T; Liu Y; Wei C; Yang Z; Chang W; Zhang X
    Biomed Pharmacother; 2020 Jan; 121():109607. PubMed ID: 31726371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The LncRNA MIR503HG/miR-224-5p/TUSC3 Signaling Cascade Suppresses Gastric Cancer Development
    Lin H; Wang J; Wang T; Wu J; Wang P; Huo X; Zhang J; Pan H; Fan Y
    Front Oncol; 2021; 11():708501. PubMed ID: 34381729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA HCP5 enhances the proliferation and migration of cervical cancer via miR-216a-5p/CDC42 axis.
    Li X; Chen B; Huang A; Ren C; Wang L; Zhu T; Xiong J; Ding W; Wang H
    J Cancer; 2022; 13(6):1882-1894. PubMed ID: 35399723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depletion of Circular RNA circ_CORO1C Suppresses Gastric Cancer Development by Modulating miR-138-5p/KLF12 Axis.
    Fan Y; Liu M; Liu A; Cui N; Chen Z; Yang Q; Su A
    Cancer Manag Res; 2021; 13():3789-3801. PubMed ID: 34007212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA HCP5 promotes neuroblastoma proliferation by regulating miR-186-5p/MAP3K2 signal axis.
    Zhu K; Wang L; Zhang X; Sun H; Chen T; Sun C; Zhang F; Zhu Y; Yu X; He X; Su Y
    J Pediatr Surg; 2021 Apr; 56(4):778-787. PubMed ID: 33189302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA NR2F2-AS1 induces epithelial-mesenchymal transition of non-small cell lung cancer by modulating BVR/ATF-2 pathway via regulating miR-545-5p/c-Met axis.
    Liu C; Li QG; Zhou Y; Cao YY; Wei ZX; Jin YH; Wang X; Chen YY; Qi L; Geng JX; Liu F
    Am J Cancer Res; 2021; 11(10):4844-4865. PubMed ID: 34765296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of lncRNA HCP5 has inhibitory effects on gastric cancer cells by regulating DDX21 expression.
    Wang K; Yu X; Tao B; Qu J
    Cytotechnology; 2021 Feb; 73(1):1-11. PubMed ID: 33505109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.